Pot investing ‘not just about hype anymore’: Supreme CEO The chief executive officer of Supreme Cannabis says that CannTrust Holdings’ ongoing regulatory scandal is shifting how investors view pot companies. “It’s going to separate good operators from the rest of the pack, because now you’re getting a lot of attention,” Supreme CEO Navdeep Dhaliwal told BNN Bloomberg Tuesday. “People are really…
Mitragyna Speciosa, also called Kratom, is a debatable mind changing drug originated naturally, which is utilized and showcased as a healthful or potential dietary enhancement. If taken in low portion, Kratom provides a stimulant impact but, at high proportion, it produces comparable impacts to that of morphine. We are quite aware that Kratom works at the narcotic receptors, modifies the…
KELOWNA, BC / ACCESSWIRE / August 13, 2019 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that its subsidiary, Lexaria CanPharm ULC., has been issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 by Health Canada with a four-year term until August 9, 2023 unless renewed. Lexaria’s new…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that Health Canada has issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 to its subsidiary, Lexaria CanPharm ULC. According to the update, the license, which carries a four-year term unless renewed, is effective immediately and will allow one of the country’s newest and most…
VANCOUVER, Aug. 12, 2019 /CNW/ – Pasha Brands Ltd. (“Pasha“) (CSE: CRFT) (OTC:CRFTF) (FSE:ZZD), North America’s largest craft cannabis brand house, is pleased to announce that its wholly owned subsidiary, BC Craft Supply Co. Ltd (“BC Craft“), has signed a supply agreement with Canada’s first licensed micro processor, North 40 Cannabis (“North 40“). Founded by Gord Nichol in Nipawin, Saskatchewan, North…
TORONTO and DENVER, Aug. 12, 2019 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that it has submitted its Evidence of Readiness package to Health Canada and completed construction on Phase 1 of “WARMAN”, a retrofitted indoor cultivation facility located in Winnipeg, Manitoba and the largest…
CannTrust Provides Interim Update VAUGHAN, ON, Aug. 12, 2019 /PRNewswire/ – CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX: TRST,NYSE: CTST) provided an interim update concerning certain recent developments affecting the Company. Heath Canada Report for Vaughan Manufacturing Facility After trading hours on Friday, August 9, 2019, CannTrust received a report from Health Canada notifying […] READ MORE: https://www.newcannabisventures.com/health-canada-accuses-canntrust-of-additional-violations/
Cronos CEO warns losses will widen Cronos Group posted a bigger-than-expected $17.8M adjusted loss in its second quarter, as costs ballooned. The company says higher processing costs and marketing expenses were partly to blame. On the conference call, CEO Mike Gorenstein also told investors to expect its adjusted EBITDA losses to widen in the second half of the year. Shares began the…
Ex-CannTrust CEO warned on governance The former chief executive of CannTrust Holdings expressed concern over the pot producer’s corporate governance practices in December, according to a letter obtained by BNN Bloomberg. Peter Aceto warned then-chairman Eric Paul that the issues needed to be resolved, and said that he “feared” his performance as CEO would suffer as a result of them. The letter,…
Despite a cool, wet start to the growing season, the pot plants were already chest high by mid-July at WeedMD Inc.’s (WMD.TO) farm in southwestern Ontario, a region better known for producing fruit and corn than cannabis. WeedMD is one of 13 Canadian pot companies that have been granted outdoor cultivation licenses in an industry that predominantly grows in greenhouses…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced successful completion of its Master Collaborative Research Agreement (“the R&D Program”) with the National Research Council of Canada (“NRC”). The R&D program sought to investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions using Lexaria’s patented DehydraTECH(TM) technology with…
(via TheNewswire) – No chemical modification or degradation of Active Pharmaceutical Ingredients evidenced using DehydraTECH after acidic pH stability testing – Strategically significant absence of covalent-bonded New Molecular Entity creation using DehydraTECH Kelowna, British Columbia – TheNewswire – August 8, 2019 – Lexaria Bioscience Corp. (OTCQX:LXRP) (CNSX:LXX.CN), (the “Company” or “Lexaria”) an innovator in drug delivery platforms, announces the successful completion of its…